Joseph Stringer
Stock Analyst at Needham
(3.17)
# 1,152
Out of 4,712 analysts
279
Total ratings
36.76%
Success rate
4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXRX Lexicon Pharmaceuticals | Reiterates: Hold | n/a | $0.77 | - | 10 | Dec 23, 2024 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Hold | n/a | $408.76 | - | 3 | Dec 20, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $60 | $35.91 | +67.08% | 17 | Dec 20, 2024 | |
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $28 | $8.18 | +242.30% | 46 | Dec 11, 2024 | |
| VIR Vir Biotechnology | Reiterates: Buy | $19 | $7.47 | +154.52% | 15 | Nov 20, 2024 | |
| ANNX Annexon | Reiterates: Buy | $16 | $5.19 | +208.29% | 17 | Nov 15, 2024 | |
| RNA Avidity Biosciences | Reiterates: Buy | $60 | $30.11 | +99.27% | 15 | Nov 13, 2024 | |
| MRNA Moderna | Reiterates: Hold | n/a | $40.13 | - | 8 | Nov 8, 2024 | |
| GILD Gilead Sciences | Reiterates: Hold | n/a | $94.11 | - | 3 | Nov 7, 2024 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $55 → $64 | $55.59 | +15.13% | 18 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $140 | $80.97 | +72.90% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $60 | $32.68 | +83.60% | 19 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $11.06 | +98.92% | 18 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $2.92 | +687.67% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $320 | $237.97 | +34.47% | 16 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $23.69 | +5.53% | 8 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $13.56 | +180.24% | 14 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.38 | - | 16 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $16.95 | +118.29% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $9.59 | +87.70% | 2 | Aug 24, 2021 |
Lexicon Pharmaceuticals
Dec 23, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.77
Upside: -
Vertex Pharmaceuticals
Dec 20, 2024
Reiterates: Hold
Price Target: n/a
Current: $408.76
Upside: -
Ionis Pharmaceuticals
Dec 20, 2024
Maintains: Buy
Price Target: $60
Current: $35.91
Upside: +67.08%
Phathom Pharmaceuticals
Dec 11, 2024
Reiterates: Buy
Price Target: $28
Current: $8.18
Upside: +242.30%
Vir Biotechnology
Nov 20, 2024
Reiterates: Buy
Price Target: $19
Current: $7.47
Upside: +154.52%
Annexon
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $5.19
Upside: +208.29%
Avidity Biosciences
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $30.11
Upside: +99.27%
Moderna
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $40.13
Upside: -
Gilead Sciences
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $94.11
Upside: -
Rhythm Pharmaceuticals
Nov 6, 2024
Maintains: Buy
Price Target: $55 → $64
Current: $55.59
Upside: +15.13%
Nov 6, 2024
Reiterates: Buy
Price Target: $140
Current: $80.97
Upside: +72.90%
Nov 6, 2024
Maintains: Buy
Price Target: $85 → $60
Current: $32.68
Upside: +83.60%
Nov 6, 2024
Reiterates: Buy
Price Target: $22
Current: $11.06
Upside: +98.92%
Nov 6, 2024
Reiterates: Buy
Price Target: $23
Current: $2.92
Upside: +687.67%
Nov 1, 2024
Reiterates: Buy
Price Target: $320
Current: $237.97
Upside: +34.47%
Aug 14, 2024
Reiterates: Buy
Price Target: $25
Current: $23.69
Upside: +5.53%
Aug 8, 2024
Reiterates: Buy
Price Target: $38
Current: $13.56
Upside: +180.24%
Jun 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.38
Upside: -
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $16.95
Upside: +118.29%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $9.59
Upside: +87.70%